padcev
astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - antineoplastiski līdzekļi - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.
fortum 1 g, pulveris injekciju šķīduma pagatavošanai
glaxosmithkline latvia, sia, latvija - ceftazidīms - pulveris injekciju šķīduma pagatavošanai - 1 g
formula iv plus (2016.) cits, tablete un kapsula
natural formulas/eurocaps limited - cits, tablete un kapsula
formula evalar (2019.) kapsula
evalar, a/s - kapsula
formula vitale man+ conception (2017.) tablete
international health solutions ltd. - tablete
formula vitale vitale woman (2017.) tablete
international health solutions ltd. - tablete
formula vitale woman 50+ (2017.) tablete
international health solutions ltd. - tablete
formula vitale pregna+ multi (2017.) tablete
international health solutions ltd. - tablete
formula vitale pregna+ omega (2017.) cits, tablete un kapsula
international health solutions ltd. - cits, tablete un kapsula
formula 2 vitamīnu un minerālvielu komplekss vīriešiem (2017.) tablete
fine foods ntm s.p.a - tablete